The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Thrombosis and Haemostasis Year : 2021

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper

1 CRSA - Centre de Recherche Saint-Antoine
2 CHU Tenon [AP-HP]
3 UNIMI - Università degli Studi di Milano = University of Milan
4 CIMI - Centre d'Immunologie et des Maladies Infectieuses
5 Sechenov First Moscow State Medical University
6 CU - Campbell University [Buies Creek, NC, USA]
7 University of Karachi
8 Universität Heidelberg [Heidelberg] = Heidelberg University
9 UNIMIB - Università degli Studi di Milano-Bicocca = University of Milano-Bicocca
10 Loyola University [Chicago]
11 CyI - Cyprus Institute
12 University of Belgrade [Belgrade]
13 NVC - Nuova Villa Claudia [Rome, Italy]
14 UCAM - Universidad Católica San Antonio de Murcia
15 Rambam Health Care Campus [Haifa, Israel]
16 Technion - Israel Institute of Technology [Haifa]
17 MHRF - Ministry of Health of the Russian Federation
18 St James's University Hospital
19 Trinity College Dublin
20 NKUA - National and Kapodistrian University of Athens
21 McMaster University [Hamilton, Ontario]
22 FIRH - Firestone Institute for Respiratory Health [Hamilton, ON, Canada]
23 Ministry of Health [Saudi Arabia]
24 SIH - Szent Imre Hospital [Budapest, Hungary]
25 Mashhad University of Medical Sciences
26 Edin. - University of Edinburgh
27 CUMS - Capital University of Medical Sciences [Beijing]
28 HUEP - Hôpitaux Universitaires de l'Est Parisien [Paris]
29 Monash Medical Centre [Clayton, Australia]
30 CUTN - Central University of Tamil Nadu [Thiruvarur, India]
31 OTRH - Okmeydani Training and Research Hospital [Istanbul, Turkey]
32 CICD - Centre International de Cancérologie de Dakar [Dakar, Senegal]
33 Aristotle University of Thessaloniki
34 University Hospital Southampton NHS Foundation Trust
35 UVS - Université Virtuelle du Sénégal [Dakar, Senegal]
36 IThEM - U1140 - Innovations thérapeutiques en hémostase = Innovative Therapies in Haemostasis
37 UCH - University Clinic of Hematology [Skopje, Republic of North Macedonia]
38 UMP - University of Medicine and Pharmacy [Cluj-Napoca, Romania]
39 2FTH - Flor Ferenc Teaching Hospital [Kistarcsa, Hungary]
40 San Camillo Forlanini Hospital [Rome]
41 LUMC - Loyola University Medical Center
42 SVRI - Science Valley Research Institute [São Paulo, Brazil]
43 KH2C - King Hussein Cancer Center [Amman, Jordan]
44 HFB - CHU Fattouma Bourguiba [Monastir]
45 Medizinische Universität Wien = Medical University of Vienna
46 Nobelpharma Co. Ltd. [Tokyo, Japan]
47 ULB - Hôpital Erasme [Bruxelles]
48 NSUC - North Shore University Cardiologists [Skokie, Illinois, USA]
49 AUB - American University of Beirut Faculty of Medicine and Medical Center
50 KEVB - Klinikum Ernst von Bergmann [Potsdam, Germany]
51 Peking University [Beijing]
52 China Academy of Chinese Medical Sciences
53 UM5 - Université Mohammed V de Rabat [Agdal]
Jawed Fareed

Abstract

Background One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis. Management Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program in many countries in late December 2020 with mRNA vaccines, adenovirus-based vaccines, and inactivated virus vaccines has generated hope for the end of the pandemic. Current Issues The continuous appearance of new pathogenic viral strains and the ability of vaccines to prevent infection and transmission raise important concerns as we try to achieve community immunity against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) and its variants. The need of a second and even third generation of vaccines has already been acknowledged by the WHO and governments. Perspectives There is a critical and urgent need for a balanced and integrated strategy for the management of the COVID-19 outbreaks organized on three axes: (1) Prevention of the SARS-CoV-2 infection, (2) Detection and early diagnosis of patients at risk of disease worsening, and (3) Anticipation of medical care (PDA). Conclusion The “PDA strategy” integrated into state policy for the support and expansion of health systems and introduction of digital organizations (i.e., telemedicine, e-Health, artificial intelligence, and machine-learning technology) is of major importance for the preservation of citizens' health and life world-wide.
Fichier principal
Vignette du fichier
a-1535-8807.pdf (623.68 Ko) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

inserm-03447118 , version 1 (24-11-2021)

Identifiers

Cite

Grigoris Gerotziafas, Mariella Catalano, Yiannis Theodorou, Patrick Van Dreden, Vincent Marechal, et al.. The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper. Thrombosis and Haemostasis, 2021, 121 (08), pp.992-1007. ⟨10.1055/a-1535-8807⟩. ⟨inserm-03447118⟩
80 View
105 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More